Adage Capital Partners GP »

Enliven Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 73k 20.47
2025-06-30 $1.9M 96k 20.06
2025-03-31 $8.9M 450k 19.68
2024-12-31 $15M 650k 22.50
2024-09-30 $20M 800k 25.54
2024-06-30 $20M 840k 23.37